Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials

Affiliations

• ¹ NCT Trial Center, National Center for Tumor Diseases Heidelberg, Germany richard.schlenk@nct-heidelberg.de.
• ² University Hospital Ulm, Department of Internal Medicine III, Germany.
• ³ Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany.
• ⁴ Hôpital Saint-Louis - Service d'Hematologie Adulte, Paris, France.
• ⁵ Department of Internal Medicine I, University of Cologne, Germany.
• ⁶ University of Dresden, Department of Internal Medicine I, Germany.
• ⁷ Universitair Ziekenhuis, Gent, Belgium.
• ⁸ Inselspital, Bern, Switzerland.
• ⁹ University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ¹⁰ Hôpital Cochin, Paris, France.
• ¹¹ The Alfred Hospital, Melbourne, VIC, Australia.
• ¹² Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine, Italy.
• ¹³ Hospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Research Institutes, Barcelona, Spain.
• ¹⁴ Novartis Pharmaceutical Corporation, East Hanover, NJ, USA.
• ¹⁵ Novartis Pharma AG, Basel, Switzerland.
• ¹⁶ University of Frankfurt, Department of Internal Medicine II, Germany.